Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809
Clinical trial NCT02068690 · COMPLETED
Trial details
- NCT number
- NCT02068690
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-20
- Primary completion
- 2014-09-10
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.